soul semaglutide Oral Gets FDA Approval for CV Event Reduction in High-risk Diabetes Patients soul trial oral semaglutide cardiovascular

Received order within days if ordering and everything I needed was n included

Although the absolute risk was small, awareness of this potential effect may support informed, patient centred treatment decisions, the study reads

You might know it by the brand names Ozempic or Wegovy

"The STEP 9 results are encouraging and provide important information about the effect of semaglutide, a glucagon-like peptide-1 receptor agonist, on knee osteoarthritis outcomes in people with obesity

While injectable GLP-1-based therapy uptake has been well documented ( 8 ), far less is known about how quickly newly approved obesity therapies are adopted in routine clinical practice, particularly in the weeks immediately following approval